EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
06.11.25
/
50%
€9.59
Target price
06.11.26
€33.89
Performance (%)
-56.21%
Price
14.08.26
€11.40
Summary
This prediction is currently active. Massive losses of -56.21% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 06.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 4.587% | 4.587% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $39.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
07.05.26
07.05.26
€31.47
07.05.27
07.05.27
15.04%
14.08.26
14.08.26
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.18
17.06.25
17.06.25
€24.24
17.06.26
17.06.26
40.62%
18.06.26
18.06.26